Info in Miami & Nationwide
"Colson Hicks Eidson is recognized as one of the top litigation firms in the country, handling local, national and international litigation for a wide range of clients." - Chambers USA
Allergan Breast Cancer No Longer Considered “Rare”
The team at Colson Hicks Eidson has worked diligently to bring you updated information regarding cancer caused by Allergan’s textured breast implants. While we wish that the latest news was more encouraging, we are sad to report that cases of this type of cancer are increasing. Our Allergan breast cancer attorneys are taking the cases of victims throughout Florida and the United States. The nationally recognized team at Colson Hicks Eidson believes that all victims deserve compensation for what has happened to them.
Problems with textured breast implants continue to rise
We have reported that the US Food and Drug Administration (FDA) has recalled textured breast implants manufactured by Allergan. This recall is due to the evidence that these implants lead to an increased risk of patients developing breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
We have reported that this type of cancer is rare, but new studies indicate that we may not be able to call it rare anymore. A new study first reported by a Canadian news agency states that Health Canada says that is has received 106 reported of BIA-ALCL. Out of those, 52 reports have come in since May 28, 2019. Two of the reports they received resulted in patient death.
One woman who was diagnosed with BIA-ALCL is concerned about this type of cancer being labeled as “rare.” She says that “We have women in Canada presenting symptoms to their physician, and the physician is telling them that they don’t have cancer and … that they should get on with their lives because of the word rare.”
McGregor was diagnosed with BIA-ALCL in 2015 and continues to undergo follow-up care.
Despite the increasing prevalence of these cases, health officials in the US and Canada have warned patients against removing textured implants unless they have tested positive for cancer. They say that removal surgeries are risky.
While we are glad that Allergan’s Biocell textured breast implants are no longer being used in this country, the team at Colson Hicks Eidson knows that women who are affected need help. They had no idea that this could happen to them, and they were not warned of the risks despite the warning signs of BIA-ALCL caused by these implants being around for years.
Let us get to work on your behalf
If you or somebody you care about has been diagnosed with cancer due to textured breast implants, seek assistance from an attorney with extensive experience with these cases. At Colson Hicks Eidson, our award-winning firm has a track record of success and is ready to help you secure the compensation you are entitled to. This can include:
- Coverage of medical expenses related to the defective breast implants
- Recovery of lost wages if you cannot work while recovering
- Pain and suffering damages
- Loss of enjoyment of life damages
- Possible punitive damages against Allergan